{"id":47880,"date":"2022-11-02T11:00:25","date_gmt":"2022-11-02T02:00:25","guid":{"rendered":"https:\/\/www.veeva.com\/jp\/?p=47880"},"modified":"2022-11-02T02:47:12","modified_gmt":"2022-11-01T17:47:12","slug":"veeva-introduces-new-epro-application-for-faster-access-to-patient-data","status":"publish","type":"post","link":"https:\/\/pantheon.veeva.com\/jp\/news\/veeva-introduces-new-epro-application-for-faster-access-to-patient-data\/","title":{"rendered":"Veeva\u3001\u88ab\u9a13\u8005\u30c7\u30fc\u30bf\u306b\u8fc5\u901f\u306b\u30a2\u30af\u30bb\u30b9\u3067\u304d\u308b\u65b0\u305f\u306aePRO\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u958b\u59cb"},"content":{"rendered":"

\uff5e Veeva ePRO\u306b\u3088\u308a\u30c7\u30b8\u30bf\u30eb\u81e8\u5e8a\u8a66\u9a13\u3067\u88ab\u9a13\u8005\u304c\u5831\u544a\u3059\u308b<\/p>\n

\u30a2\u30a6\u30c8\u30ab\u30e0\u306e\u53ce\u96c6\u3068\u4ea4\u63db\u3092\u7c21\u7d20\u5316 \uff5e<\/p>\n

 <\/p>\n

2022\u5e7411\u67082\u65e5<\/p>\n

Veeva Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n

 <\/p>\n

Veeva Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : Sebastian Bather\u3001\u4ee5\u4e0b Veeva) \u306f\u3001\u60a3\u8005\u4e2d\u5fc3\u306e\u30c7\u30b8\u30bf\u30eb\u81e8\u5e8a\u8a66\u9a13\u3092\u5927\u304d\u304f\u524d\u9032\u3055\u305b\u308bVeeva ePRO<\/a><\/strong>\u306e\u63d0\u4f9b\u958b\u59cb(\u65e5\u672c\u5c0e\u5165\u6642\u671f\u306f\u672a\u5b9a)\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u3053\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3067\u306f\u3001\u88ab\u9a13\u8005\u304c\u30e2\u30d0\u30a4\u30eb\u30c7\u30d0\u30a4\u30b9\u3001\u3042\u308b\u3044\u306fWeb\u30d6\u30e9\u30a6\u30b6\u304b\u3089\u5bb9\u6613\u306b\u8a55\u4fa1\u9805\u76ee\u3092\u5165\u529b\u3067\u304d\u308b\u305f\u3081\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u304a\u3088\u3073\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306f\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u3067\u306e\u30c7\u30fc\u30bf\u30a2\u30af\u30bb\u30b9\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002\u8a66\u9a13\u30c1\u30fc\u30e0\u306f\u81e8\u5e8a\u8a66\u9a13\u7528\u306e\u30b3\u30cd\u30af\u30c6\u30c3\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3068\u3057\u3066ePRO\u3092\u4f7f\u7528\u3057\u3001\u30af\u30ea\u30cb\u30ab\u30eb\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u5168\u4f53\u3067\u9ad8\u54c1\u8cea\u306e\u30c7\u30fc\u30bf\u3092\u4ea4\u63db\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u3001\u900f\u660e\u6027\u3068\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u5411\u4e0a\u3055\u305b\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002 (\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001Veeva\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/strong><\/a>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n

 <\/p>\n

\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u304c\u88ab\u9a13\u8005\u306e\u8a66\u9a13\u53c2\u52a0\u7d99\u7d9a\u306b\u304a\u3051\u308b\u6700\u5927\u306e\u8ab2\u984c\u3068\u3057\u3066\u6319\u3052\u3066\u3044\u308b\u306e\u306f\u3001\u8a66\u9a13\u53c2\u52a0\u306b\u8981\u3059\u308b\u6642\u9593\u3068\u7e70\u308a\u8fd4\u3057\u8981\u6c42\u3055\u308c\u308b\u60c5\u5831\u63d0\u4f9b\u3001\u30c7\u30fc\u30bf\u5165\u529b\u306b\u8981\u3059\u308b\u6642\u9593\u3067\u3059[1]<\/sup><\/a><\/strong>\u3002Veeva ePRO\u306f\u30e6\u30fc\u30b6\u30fc\u30d5\u30ec\u30f3\u30c9\u30ea\u30fc\u306a\u6700\u65b0\u306e\u60a3\u8005\u5831\u544a\u30a2\u30a6\u30c8\u30ab\u30e0\uff08PRO\uff09\u5165\u529b\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3057\u3001\u60a3\u8005\u4f53\u9a13\u3092\u5411\u4e0a\u3055\u305b\u307e\u3059\u3002<\/p>\n

\u3053\u306e\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u306f\u30b9\u30dd\u30f3\u30b5\u30fc\u3068\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306e\u81e8\u5e8a\u8a66\u9a13\u696d\u52d9\u306e\u30b9\u30ea\u30e0\u5316\u306b\u3082\u8ca2\u732e\u3057\u307e\u3059\u3002\u30b9\u30dd\u30f3\u30b5\u30fc\u306f\u8abf\u67fb\u304a\u3088\u3073\u6a5f\u5668\u30e9\u30a4\u30d6\u30e9\u30ea\u3092\u7528\u3044\u3066\u8a66\u9a13\u306e\u5404\u7a2e\u8a2d\u5b9a\u3092\u884c\u3044\u3001ePRO\u304a\u3088\u3073\u30b9\u30b1\u30b8\u30e5\u30fc\u30eb\u5b9a\u7fa9\u3092\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306b\u5f8c\u62bc\u3057\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306f\u30a2\u30af\u30c6\u30a3\u30d3\u30c6\u30a3\u306e\u5272\u5f53\u3066\u3084\u3001\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u306e\u81ea\u52d5\u53d7\u4fe1\u3001\u88ab\u9a13\u8005\u306e\u9032\u6357\u72b6\u6cc1\u306e\u8ffd\u8de1\u304c\u5bb9\u6613\u306b\u306a\u308a\u3001\u4ed6\u306e\u30b7\u30b9\u30c6\u30e0\u3084\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u4f7f\u7528\u3059\u308b\u5fc5\u8981\u304c\u306a\u304f\u306a\u308a\u307e\u3059\u3002<\/p>\n

Veeva\u306eMyVeeva for Patients\u62c5\u5f53\u30b9\u30c8\u30e9\u30c6\u30b8\u30fc\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308bTim Davis\u306f\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300cVeeva ePRO\u306f\u60a3\u8005\u69d8\u3001\u8a66\u9a13\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u4f01\u696d\u306e\u7686\u69d8\u306e\u30cb\u30fc\u30ba\u3092\u6e80\u305f\u3059\u3088\u3046\u8a2d\u8a08\u3055\u308c\u3066\u304a\u308a\u3001\u30a8\u30f3\u30c9\u30c4\u30fc\u30a8\u30f3\u30c9\u306a\u8a66\u9a13\u5b9f\u65bd\u304c\u3067\u304d\u308b\u3088\u3046\u9023\u643a\u3055\u308c\u3066\u3044\u307e\u3059\u3002Veeva\u306f\u304a\u5ba2\u69d8\u3068\u306e\u5354\u696d\u306b\u3088\u308a\u3001\u60a3\u8005\u4e2d\u5fc3\u306e\u30c7\u30b8\u30bf\u30eb\u81e8\u5e8a\u8a66\u9a13\u3078\u5411\u3051\u305f\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u524d\u9032\u306b\u5bc4\u4e0e\u3059\u308b\u3001\u6700\u65b0\u306e\u30c7\u30b8\u30bf\u30eb\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u63d0\u4f9b\u3067\u304d\u308b\u3088\u3046\u5c3d\u529b\u3057\u3066\u3044\u307e\u3059\u3002\u300d<\/p>\n

Veeva ePRO\u306f\u30af\u30ea\u30cb\u30ab\u30eb\u30c7\u30fc\u30bf\u30de\u30cd\u30b8\u30e1\u30f3\u30c8\u3068\u30af\u30ea\u30cb\u30ab\u30eb\u30aa\u30da\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u7d71\u5408\u5316\u3059\u308b\u696d\u754c\u521d\u306e\u30af\u30e9\u30a6\u30c9\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3042\u308bVeeva Vault Clinical Suite<\/a><\/strong>\u306e\u4e00\u90e8\u3067\u3059\u3002Vault Clinical Suite\u306fVault EDC<\/a><\/strong>\u3001Veeva RTSM<\/a><\/strong>\u3001Veeva ePRO\u3001Veeva CDB<\/a><\/strong>\u3001Vault eTMF<\/a><\/strong>\u3001Vault CTMS<\/a><\/strong>\u3001Veeva Site Connect<\/a><\/strong>\u3001Vault Payments<\/a><\/strong>\u3001Vault Study Start-up<\/a><\/strong>\u3001Vault Study Training<\/a><\/strong>\u304b\u3089\u69cb\u6210\u3055\u308c\u3066\u3044\u307e\u3059\u3002Veeva ePRO\u306b\u3064\u3044\u3066\u306e\u8a73\u7d30\u306f\u3001veeva.com\/ePRO<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n

 <\/p>\n

[1]<\/a> SCRS \u8abf\u67fb\u30ec\u30dd\u30fc\u30c8Impact Assessment of eClinical Technologies and Industry Initiatives on Sites<\/a>, 2019<\/span><\/p>\n

 <\/p>\n

\u3010<\/strong>Veeva Systems<\/strong>\u793e\u306b\u3064\u3044\u3066\u3011<\/strong>
\nVeeva Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u5411\u3051\u306b\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u30671,100\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u3001\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30d1\u30d6\u30ea\u30c3\u30af\u30fb\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30b3\u30fc\u30dd\u30ec\u30fc\u30b7\u30e7\u30f3\u4f01\u696d\u3068\u3057\u3066Veeva\u306f\u3001\u9867\u5ba2\u3084\u5f93\u696d\u54e1\u3001\u63d0\u643a\u4f01\u696d\u3001\u682a\u4e3b\u3001\u30b5\u30fc\u30d3\u30b9\u63d0\u4f9b\u696d\u754c\u3092\u542b\u3080\u3059\u3079\u3066\u306e\u30b9\u30c6\u30fc\u30af\u30db\u30eb\u30c0\u30fc\u306e\u5229\u76ca\u30d0\u30e9\u30f3\u30b9\u3092\u4fdd\u3064\u3053\u3068\u306b\u30b3\u30df\u30c3\u30c8\u3057\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001veeva.com\/jp<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n

\u3010Forward-looking Statements<\/strong>\u3011<\/strong>
\nThis release contains forward-looking statements regarding Veeva\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended July 31, 2022, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 39 and 40), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Veeva ePro\u306b\u3088\u308a\u3001\u5b9f\u65bd\u533b\u7642\u6a5f\u95a2\u306f\u30a2\u30af\u30c6\u30a3\u30d3\u30c6\u30a3\u306e\u5272\u5f53\u3066\u3084\u3001\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8\u306e\u81ea\u52d5\u53d7\u4fe1\u3001\u88ab\u9a13\u8005\u306e\u9032\u6357\u72b6\u6cc1\u306e\u8ffd\u8de1\u304c\u5bb9\u6613\u306b\u306a\u308a\u3001\u4ed6\u306e\u30b7\u30b9\u30c6\u30e0\u3084\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3092\u4f7f\u7528\u3059\u308b\u5fc5\u8981\u304c\u306a\u304f\u306a\u308a\u307e\u3059\u3002<\/p>\n","protected":false},"author":131,"featured_media":47885,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-47880","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/47880"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=47880"}],"version-history":[{"count":6,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/47880\/revisions"}],"predecessor-version":[{"id":47888,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/47880\/revisions\/47888"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media\/47885"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=47880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=47880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=47880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}